id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0579-0003,FDA,FDA-2009-D-0579,"International Conference on Harmonisation: Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts, etc.; Availability",Notice,Notice of Availability,2010-09-03T04:00:00Z,2010,9,2010-09-03T04:00:00Z,,2020-05-06T02:07:52Z,2010-21991,0,0,0900006480b4495c
FDA-2009-D-0579-0005,FDA,FDA-2009-D-0579,Guidance for Industry; Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex 12; Analytical Sieving General Chapter,Other,Guidance,2010-09-02T04:00:00Z,2010,9,2010-09-02T04:00:00Z,,2024-11-12T23:19:46Z,,1,0,090000648456e7b8
FDA-2009-D-0579-0004,FDA,FDA-2009-D-0579,Guidance for Industry; Q4B Evaluation and Recommenations of Pharmacopoeial Texts for Use in the ICH Regions; Annex 11 Capillary Electrophoresis General Chapter,Other,Guidance,2010-09-02T04:00:00Z,2010,9,2010-09-02T04:00:00Z,,2020-06-26T18:05:25Z,,0,0,0900006480b44db7
FDA-2009-D-0579-0001,FDA,FDA-2009-D-0579,International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International,Notice,NAD-Notice of Availability of Data,2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-17T04:59:59Z,2009-12-17T19:32:00Z,E9-29990,0,0,0900006480a6c715
FDA-2009-D-0579-0002,FDA,FDA-2009-D-0579,Q4B Evaluation and Recommenations of Pharmacopoeial Texts for Use in the ICH Regions - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2009-12-17T05:00:00Z,2009,12,2009-12-17T05:00:00Z,2010-02-17T04:59:59Z,2009-12-17T19:31:20Z,,0,0,0900006480a6cf78